Published in Endokrynol Pol on June 26, 1979
1,161 patients with adrenal incidentalomas: indications for surgery. Langenbecks Arch Surg (2007) 1.34
Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf) (1997) 1.24
Incidentally discovered adrenal tumors: a lesson from observation of 1,444 patients. Horm Metab Res (2008) 1.10
Low-molecular-weight heparins: pharmacologic profile and product differentiation. Am J Cardiol (1998) 0.99
Adrenocortical carcinoma. A clinical study and treatment results of 52 patients. Cancer (1995) 0.98
Molecular profiling and weight determination of heparins and depolymerized heparins. J Pharm Sci (1995) 0.89
Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation. Br J Haematol (2000) 0.87
Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction. Atherosclerosis (1989) 0.86
[Antibodies directed against adrenal glands in Addison's and Cushing's diseases]. Pol Arch Med Wewn (1971) 0.86
Leptin and ghrelin concentrations and weight loss in Parkinson's disease. Acta Neurol Scand (2009) 0.85
Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensis. Biochim Biophys Acta (1999) 0.85
Downregulation of clusterin expression in testicular germ cell tumours. Pathobiology (2001) 0.85
Ectopic ACTH syndrome due to bilateral ovarian androblastoma with double, gynandroblastic differentiation in one ovary. Eur J Obstet Gynecol Reprod Biol (1993) 0.84
Low molecular weight heparins: are they different? Can J Cardiol (1998) 0.83
The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome. J Endocrinol Invest (1991) 0.83
In vitro studies on the effect of activated protein C on platelet activation and thrombin generation. Thromb Res (1997) 0.82
The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome. Acta Endocrinol (Copenh) (1979) 0.82
[Clinical significance of anti-tbyroid antibodies in Addison's disease]. Pol Tyg Lek (1978) 0.81
Nelson's syndrome -- 46 years later: clinical experience with 37 patients. Zentralbl Neurochir (2006) 0.81
Effect of clonidine on beta-endorphin, ACTH and cortisol secretion in essential hypertension and obesity. Eur J Clin Pharmacol (1988) 0.81
[Radioimmunoassay of total serum thyroxine and triiodothyronine]. Endokrynol Pol (1977) 0.81
Comparative tissue factor pathway inhibitor release potential of heparins. Clin Appl Thromb Hemost (2005) 0.80
TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin. Thromb Res (1995) 0.80
Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women. J Endocrinol Invest (1992) 0.80
The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin. Blood Coagul Fibrinolysis (1995) 0.79
Chylothorax in infancy. Thorax (1968) 0.79
Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, Suleparoide. Semin Thromb Hemost (1993) 0.79
Nelson's syndrome: incidence and prognosis. Clin Endocrinol (Oxf) (1983) 0.79
Antithrombotic agents stimulate the synthesis and modify the sulfation pattern of a heparan sulfate proteoglycan from endothelial cells. Thromb Res (1994) 0.79
Serum prolactin responses to metoclopramide in Cushing's syndrome and Nelson's syndrome. Acta Endocrinol (Copenh) (1980) 0.79
Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease. J Intern Med (1995) 0.78
The role of sex hormones in the mechanism of inhibited LH release in female patients with anorexia nervosa. Acta Endocrinol (Copenh) (1982) 0.78
Comment of long-acting lanreotide inducing clinical and biochemical remission of acromegaly caused by disseminated GHRH secreting carcinoid. J Clin Endocrinol Metab (1999) 0.77
Cytostatics for acromegaly. Marked improvement in a patient with an invasive pituitary tumour. Acta Endocrinol (Copenh) (1987) 0.77
Anticoagulant and antithrombotic actions of a semisynthetic beta-1,3-glucan sulfate. Thromb Res (1995) 0.77
Enhanced testosterone in female patients with anorexia nervosa: its normalization after weight gain. Acta Endocrinol (Copenh) (1979) 0.77
Are the available low-molecular-weight heparin preparations the same? Semin Thromb Hemost (1996) 0.77
Preclinical studies on a low molecular weight heparin. Thromb Res (1996) 0.77
Physical and pharmacologic manipulation of the vascular system as measured by the release of TFPI and other mediators of antithrombotic actions. Int Angiol (1996) 0.77
Serum prolactin in women with premenstrual syndrome. Mater Med Pol (1982) 0.77
Antidiuretic effect of sulfonylureas in idiopathic diabetes insipidus. Helv Med Acta (1969) 0.76
The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion. J Clin Endocrinol Metab (1984) 0.76
[Serum concentration of triiodothyronine, thyroxine and thyrotropin in elderly]. Endokrynol Pol (1977) 0.76
Exaggerated growth hormone response to growth hormone-releasing hormone in type I diabetes mellitus. Acta Endocrinol (Copenh) (1988) 0.76
Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate. Int Angiol (2008) 0.76
The effect of naloxone on ATCH and beta-endorphin in patients with Cushing's disease. Acta Endocrinol (Copenh) (1985) 0.76
Radioimmunological determination of exogenous corticotropin-releasing hormone (CRH) and growth hormone-releasing hormone (GHRH): plasma half-life of CRH and GHRH. Endokrynol Pol (1989) 0.76
Enhancement of plasma corticotropin-releasing hormone in pregnancy-induced hypertension. Acta Endocrinol (Copenh) (1990) 0.76
Low molecular weight heparins: a developmental perspective. Expert Opin Investig Drugs (1997) 0.76
Inhibitory effects of TFPI on thrombin and factor Xa generation in vitro--modulatory action of glycosaminoglycans. Thromb Res (1994) 0.76
Incidentally found adrenal tumours: results of investigation of the pituitary-adrenal axis. Endokrynol Pol (1992) 0.75
Management of Nelson's syndrome: observations in fifteen patients. Clin Endocrinol (Oxf) (2001) 0.75
Cushing's syndrome in a 16-year-old girl due to ectopic ACTH precursor production from a pancreatic tumour. Clin Endocrinol (Oxf) (2001) 0.75
The effect of oral ethanol ingestion on the diurnal neurotensin secretion in man. Endokrynol Pol (1992) 0.75
Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human blood. Blood Coagul Fibrinolysis (1999) 0.75
Cushing's syndrome secondary to ectopic ACTH secretion from a primary ovarian carcinoma. Clin Endocrinol (Oxf) (1997) 0.75
[Antidiuretic action of chlorpropamide in diabetes insipidus caused by vasopressin deficiency]. Pol Arch Med Wewn (1972) 0.75
[Effect of hypercalcemia on the secretion of insulin and anterior pituitary hormones]. Endokrynol Pol (1984) 0.75
[Prolactin secretion in patients with hyperthyroidism]. Pol Tyg Lek (1985) 0.75
[Different hypogonadism mechanism in men and women suffering from Cushing's disease]. Endokrynol Pol (1981) 0.75
[Attempt at diagnosis of pituitary microadenomas as a cause of spontaneous hyperprolactinemia]. Endokrynol Pol (1981) 0.75
[Relationship between clinical classification of hyperthyroidism for three grades of severity and level of triiodothyronine (T3) and thyroxine (T4) concentrations in serum]. Endokrynol Pol (1992) 0.75
[Hyperaldosteronism after metoclopramide administration]. Pol Arch Med Wewn (1980) 0.75
[Hypothyroidism and pregnancy]. Pol Tyg Lek (1986) 0.75
Effects of transdermal 17 beta-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic postmenopausal women. J Intern Med (1993) 0.75
[Effect of calcitonin on the secretion of PRL, TSH, GH, LH, FSH, cortisol, T3 and T4]. Endokrynol Pol (1984) 0.75
[Alcohol decreases the alpha subunit, LH and testosterone secretion in response to LH-RH]. Endokrynol Pol (1992) 0.75
[Increased reverse triiodothyronine concentration in anorexia nervosa]. Endokrynol Pol (1981) 0.75
The effect of D-Trp6-LRH upon secretion of gonadotrophin--a possible therapeutic application in anorexia nervosa. Acta Endocrinol (Copenh) (1984) 0.75
[Studies on the pathogenesis of arterial hypertension in acromegaly. I. The renin-angiotensin-aldosterone system]. Pol Arch Med Wewn (1983) 0.75
[Mechanism of hormonal action mediated by cyclic 3', 5' AMP]. Pol Arch Med Wewn (1975) 0.75
Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report. Mater Med Pol (1982) 0.75
Evidence for alpha-adrenergic receptors mediated TSH release in men. Acta Endocrinol (Copenh) (1980) 0.75
[Treatment of the malignant phase of infiltrative-edematous exophthalmos in Graves-Basedow disease]. Pol Tyg Lek (1985) 0.75
Radioimmunological determination of beta-endorphin-like substance in human blood plasma and urine. Endokrynol Pol (1986) 0.75
[Solid phase radioimmunoassay for human growth hormone]. Endokrynol Pol (1978) 0.75
[Effect of metoclopramide and acth on aldosterone secretion in patients with insufficiency of the anterior pituitary gland]. Pol Arch Med Wewn (1985) 0.75
[Long-term inhibition of growth hormone secretion after alcohol intake. Disorders of physiological diurnal rhythm]. Pol Tyg Lek (1985) 0.75
[Role of hormonal disorders in the etiology of polycystic ovary syndrome (Stein-Leventhal syndrome)]. Endokrynol Pol (1982) 0.75
[Hypogonadotropinemia in women with Cushing's syndrome]. Endokrynol Pol (1980) 0.75
The effect of naloxone on the secretion of pituitary hormones in patients with acromegaly, microprolactinomas, Cushing's disease and Nelson's syndrome. Endokrynol Pol (1986) 0.75
TRH-induced growth hormone release in insulin-dependent diabetes mellitus. Horm Metab Res (1984) 0.75
[Effect of synthetic LH-RH on the secretion of LM, FSH and testosterone in Stain-Leventhal syndrome]. Endokrynol Pol (1978) 0.75
[Diurnal rhythm of prolactin secretion after excessive intake of alcohol]. Endokrynol Pol (1984) 0.75
Methodologic basis for the radioimmunoassay of endogenous LH-like activity in human prostatic tissue. Nuklearmedizin (1983) 0.75
[Excessive secretion of antidiuretic hormone (Schwartz-Bartter syndrome)]. Pol Arch Med Wewn (1971) 0.75
Mixed pituitary tumours--effects of bromocriptine treatment: Parlodel MR and Parlodel LAR. Endokrynol Pol (1992) 0.75
[Diurnal rhythm of prolactin secretion in women with primary hypothyroidism]. Endokrynol Pol (1984) 0.75
Thyrotropin-releasing hormone (TRH) does not suppress growth hormone response to L-dopa in insulin-dependent diabetes mellitus. Endokrynol Pol (1992) 0.75
[Effect of endogenous glucocorticosteroids on TRH-induced TSH secretion]. Endokrynol Pol (1978) 0.75
Lower 24-hour growth hormone levels in type I diabetics responding to thyrotropin-releasing hormone (TRH). Endokrynol Pol (1992) 0.75
Clinical applications of radioimmunoassay of the alpha-subunit of glycoprotein hormones. Endokrynol Pol (1992) 0.75
[Studies on the pathogenesis of arterial hypertension in acromegaly. II. Disorders of prolactin secretion]. Pol Arch Med Wewn (1983) 0.75
[Dissociation of the renin-angiotensin-aldosterone system in hyperthyroidism]. Pol Tyg Lek (1985) 0.75
[Pulmonary infarction and pulmonary artery embolism]. Pol Tyg Lek (1966) 0.75
Effect of insulin-induced hypoglycemia on plasma renin activity and aldosterone and cortisol concentration in humans. Endokrynol Pol (1986) 0.75